Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation

Endocrinology

Volumn 139, Issue 8, 1998, Pages 3456-3464

  Damon, Susan E ^a,b   Maddison, Lisette ^a,b   Ware, Joy L ^c   Plymate, Stephen R ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 4;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE TUMOR;

EID: 0031789296     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.8.6150     Document Type: Article

References (50)

1. Baserga R 1995 The insulin-like growth factor receptor: a key to tumor growth? Cancer Res 55:249-252
2. LeRoith D, Werner H, Beitner-Johnson D, Roberts C 1995 The molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
3. Kelly KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson DM, Rosenfeld RG 1996 Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28:619-637
4. Oh Y, Nagalla R, Yamanaka Y, Kim H. Wilson E, Rosenfeld R 1996 Synthesis and characterization of insulin-like growth factor-binding protein IGFBP-7. J Biol Chem 271:30322-30325
5. Kim H-O, Nagalla SR, Oh Y, Wilson E, Roberts CT, Rosenfeld R 1997 Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of a connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA 94:12981-12986
6. Conover CA 1996 Regulation and physiological role of insulin-like growth factor binding proteins. Endocr J 43:S43-S48
7. Roberts C, LeRoith D 1988 Molecular aspects of insulin-like growth factor, their binding proteins and receptors. Baillere's Clin Endocrinol Metab 2:1069-1085
8. Rosenfeld R 1987 Somatomedin action and tissue growth factor-factor receptors. In: Robbins RJ, Memmed S, (eds) Acromegaly. Plenum Press, NY, pp 45-53
9. Cohen P, Peehl DM, Lamson G, Rosenfeld RG 1991 Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 73:401-407
10. Fiorelli G, de Bellis A, Longo A, Pioli P, Costantini A, Giannini S, Forti G, Serio M 1991 Growth factors in the human prostate. J Steroid Biochem Mol Biol 40:199-205
11. Fiorelli G, de Bellis A, Longo A, Giannini S, Natali A, Costantini A, Vannelli G, Serio M 1991 Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J Clin Endocrinol Metab 72:740-746
12. Tennant M, Thrasher JB, Twomey A, Drivdahl R, Birnbaum R, Plymate S 1996a Protein and messenger ribonucleic acid (mRNA) for the type-I insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinl Metab 81:3774-3782
13. Cohen P, Peehl DM, Baker B, Lui F, Hintz RL, Rosenfeld R 1994 Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Metab 79:1410-1415
14. Bonnet P, Reiter E, Bruyninx M, Sente B, Drombrowicz D, de Levai J, Closset J, Hennen G 1993 Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5a-reductase and steroid receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J Clin Endocrinol Metab 77:1203-1208
15. Boudon C, Rodier G, Lechevallier E, Mottet N, Barenton N, Sultan Ch 1996 Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture. J Clin Endocrinol Metab 81:612-617
16. Tennant M, Thrasher JB, Twomey PA, Birnbaum R, Plymate S 1996 Insulin-like growth factor-binding protein-2and -3 expression in benign human prostate epithelium. Prostate intreepithelial neoplasia, and adenocarcinoma of the prostate. J Clin Endocrinol Metab 81:411-420
17. Tennant M, Thrasher JB, Twomey PA, Birnbaum R, Plymate S 1996 Insulin-like growth factor-binding proteins (IGFBP)-4, -5, and -6 in the benign and malignant human prostate: 1GFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization. J Clin Endocrinl Metab 81:3783-3792
18. Pekonen F, Partanen S, Makinen T, Rutaned EM 1988 Receptors for epidermal growth factor and insulin-like growth factor I and their relationship to steroid receptors in human breast cancer. Cancer Res 48:1343-1347
19. Papa V, Gliozzo B, Clark G, MaGuire WL, Moore D, Fujita-Yamaguchi Y, Vigneri R, Goldfine ID, Pezzino V 1993 Insulin-like growth factor-I receptors are overexpressed and predict low risk in human breast cancer. Cancer Res 53:3736-3740
20. Bergmann U, Funatomi H, Yokoyama M, Berger H, Kore M 1995 Insulin-like growth factor-I receptors overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 55:2007-2011
21. Tanaka R, Tshushima T, Murakami H, Shizumi K, Obara T 1994 Insulin-like growth factor-I receptors and insulin-like growth factor binding proteins in human parathyroid tumors. World J Surg 18:635-642
22. Plymate S, Tennant M, Birnbaum R, Thrasher JB, Chatta G, Ware J 1996 The effect of the insulin-like growth factor system in human prostate of immortalization and transformation by Simian virus-40 T antigen. J Clin Endocrinol Metab 81:3709-3716
23. Plymate S, Hwa V, Thomasini C, Maddison L, Thrasher JB, Swisshelm K, Rosenfeld RG, Insulin-like growth factor binding protein-7 expression and regulation in the human prostate. Program of the 79th Annual Meeting of the Endocrine Society, Minneapolis, MN, 1997, p 351 (Abstract)
24. O'Conner R, Kauffman-Zeh A, Liu Y, Lehar S, Evans G, Baserga R, Blatter W 1997 Identification of domains on the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol 17:427-435
25. Blakesley V, Kalebic T, Helman L, Stannard B, Faria T, Roberts Jr C, LeRoith D 1996 Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250:1251, and 1316 in the carboxy-terminus of the IGF-I receptors. Endocrinology 137:410-417
26. Burfeind P, Chernicky C, Rininsland F, Ilan J, Ilan J 1996 Antisense RNA to the type-I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci USA 93:7263-7268
27. Bae V, Jackson-Cook C, Maygarden S, Edelman W, Brothman A, Chen J, Ware JL 1995 A new model for cytogenetic analysis of human prostate cancer progression and metastasis. Cancer Res 36:642
28. Bae V, Jackson-Cook C, Brothman A, Maygarden S, Ware JL 1994 Tumorigenecity of SV40 T antigen immortalized human prostate epithelial cells association with decreased epidermal growth factor receptor (EGFR) expression. Int J Cancer 58:721-729
29. Bae V, Jackson-Cook C, Maygarden S, Plymate S, Chen J, Ware JL 1998 Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line. Prostate 34:275-282
30. Shimasaki S, Ling N 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog Growth Factor Res 3:243-266
31. Gibson-D'Ambrosia R, Brady T, D'Ambrosia D 1995 Identification and isolation of human epithelial cell colonies that express specific gene products. Biotechniques 19:784-790
32. Birnbaum RS, Wiren KW 1994 Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts. Endocrinology 135:223-230
33. 2+ associated with apoptosis. In: Schwartz LM, Osborne BA (eds) Cell Death. Academic Press, San Diego, pp 43-46
34. Peehl DM, Stamey TA 1986 Serum free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 22:82:90
35. Singh P, Dai B, Dhruva B, Widen S 1994 Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I. Cancer Res 54:6563-6570
36. Evans GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC 1992 Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128
37. Harrington EA, Bennett MR, Fanidi A, Evans GI 1994 c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295
38. Sell C, Baserga R, Rubin R 1993 Insulin-like growth factor (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res 55:303-306
39. Mathews CC, Feldman EL 1996 Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. J Cell Physiol 166:323-331
40. Conover CA, Perry JE, Tindall DJ 1995 Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor binding proteins in cultured human prostatic carcinoma cells. J Clin Endocrinol Metab 80:987-993
41. Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A, Baserga R 1993 Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-I IGF receptor. Proc Natl Acad Sci USA 90:11217-11221
42. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R 1994 Effect of a null mutation of the type-I IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 14:3604-3612
43. Plymate SR, Bae VL, Maddison L, Quinn LS, JL 1997 Reexpression of the type-I insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells. Endocrinology 138:1728-1735
44. Wang Z-H, Ma J, Zeng B-J, Catanese VM, Samuels S, Gama Sosa MA, Kolodny EH 1997 Correlation of glioma cell regression with inhibition of insulin-like growth factor I and insulin-like growth factor-binding protein-2 expression. Neuroendocrinology 66:203-211
45. Reeve JG, Kirby LB, Brinkman A 1992 Insulin-like growth factor-binding protein gene expression and protein production by human tumor cell lines. Int J Cancer 51:818-821
46. Adamo ML, Shao ZM, Lannau F, Chen J.C, Clemmons DR, Roberts CT, LeRoith D, Fontana JA 1992 Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line. Endocrinology 131:1858-1866
47. Plymate S, Bae V, Maddison L, Quinn L, Ware J 1997 Type-I insulin-like growth factor receptor re-expression in the malignant phenotype of SV40-immortalized human prostate epithelial cells enhances apoptosis. Endocrine 7:1-6
48. Liu Y, Lehar S, Corvi C, Payne G, O'Conner R 1998 Expression of the insulin-like growth factor I receptor C terminus as a myristilated protein leads to induction of apoptosis in tumor cells. Cancer Res 58:570-576
49. O'Conner R, Kaufmann-Zeh A, Lui Y, Lehar S, Evans GI, Baserga R, Blätter WA 1997 Identification of domains of the IGF-IR that are required for protection from apoptosis. Mol Cell Biol 17:427-435
50. Rubini M, Hongo A, D'Ambrosio C, Baserga R 1997 The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp Cell Res 230:284-292